Literature DB >> 28025656

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor.

Marios Politis1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28025656     DOI： 10.1007/s00259-016-3597-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  34 in total

1.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  FDG PET in the differential diagnosis of parkinsonian disorders.

Authors:  Thomas Eckert; Anna Barnes; Vijay Dhawan; Steve Frucht; Mark F Gordon; Andrew S Feigin; D Eidelberg
Journal:  Neuroimage       Date:  2005-04-26       Impact factor: 6.556

3.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

4.  Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.

Authors:  Rahyeong Juh; Chi-Un Pae; Tae-Suk Kim; Chang-Uk Lee; Boyoung Choe; Taesuk Suh
Journal:  Neurosci Lett       Date:  2005-04-21       Impact factor: 3.046

5.  Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.

Authors:  Y Nagahama; H Fukuyama; N Turjanski; A Kennedy; H Yamauchi; Y Ouchi; J Kimura; D J Brooks; H Shibasaki
Journal:  Mov Disord       Date:  1997-09       Impact factor: 10.338

6.  Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography.

Authors:  G Rosenthal; S Gilman; R A Koeppe; K J Kluin; D S Markel; L Junck; S S Gebarski
Journal:  Ann Neurol       Date:  1988-09       Impact factor: 10.422

7.  Cerebral blood flow and metabolism in multiple system atrophy of the Shy-Drager syndrome type: a PET study.

Authors:  M Ogawa; H Fukuyama; K Harada; J Kimura
Journal:  J Neurol Sci       Date:  1998-06-30       Impact factor: 3.181

8.  Imaging dopamine receptors in the human brain by positron tomography.

Authors:  H N Wagner; H D Burns; R F Dannals; D F Wong; B Langstrom; T Duelfer; J J Frost; H T Ravert; J M Links; S B Rosenbloom; S E Lukas; A V Kramer; M J Kuhar
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

9.  Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

Authors:  I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1996-01       Impact factor: 3.685

10.  The metabolic topography of parkinsonism.

Authors:  D Eidelberg; J R Moeller; V Dhawan; P Spetsieris; S Takikawa; T Ishikawa; T Chaly; W Robeson; D Margouleff; S Przedborski
Journal:  J Cereb Blood Flow Metab       Date:  1994-09       Impact factor: 6.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.